Main > ONCOLOGY (**) > Lung>SCLC>ES SCLC > USA. A. BiSpecific DLL3-Directed>

---

USA. A. BiSpecific DLL3-Directed>'s subsections
(*) USA Approval Date: 2024. 05.16
>CD3-T-Cell Engager IV Injection
Company
Generic Name
TM
TM Web-Site
WIPO Patent Number

USA. A. BiSpecific DLL3-Directed>'s products
This section has no products